Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
about
Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbitsIn vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell linesThe cancer stem cell: evidence for its origin as an injured autoreactive T cellMolecular cancer prevention: Current status and future directionsChemoprevention in familial adenomatous polyposisEffects of supplemental vitamin D and calcium on normal colon tissue and circulating biomarkers of risk for colorectal neoplasmsSulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethaneNon-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferationChemoprevention of colorectal cancerCyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect?Effects of sulindac on sporadic colorectal adenomatous polypsFamilial adenomatous polyposis.The regulation of β-catenin activity and function in cancer: therapeutic opportunitiesRoles for inflammation and regulatory T cells in colon cancer.Unifying roles for regulatory T cells and inflammation in cancer.Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.Regression of Colonic Adenomas After Treatment With Sulindac in Familial Adenomatous Polyposis: A Case With a 2-Year Follow-up Without a Prophylactic Colectomy.Primary prevention of colorectal cancer.Chemoprevention in patients with genetic risk of colorectal cancersPatients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2Dietary calcium does not reduce experimental colorectal carcinogenesis after small bowel resection despite reducing cellular proliferationSulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factorsNon-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers.Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.Perspectives in cancer chemoprevention.Clinical trials update: Tertiary prevention of colorectal cancer.Nonhormonal drugs and cancerAspirin and familial adenomatous polyposis: coming full circleAspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus.Dual roles of immune cells and their factors in cancer development and progressionPharmacological and dietary prevention for colorectal cancer.Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenomaEffect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programmeRectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac.Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients.Non-steroidal anti-inflammatory drugs and colorectal cancer prevention
P2860
Q24620457-A926E627-135E-4F23-B925-A2E429F29A85Q24650329-3F5B6279-4148-40AB-A789-05F55A864DACQ24792522-D5A9E516-BF16-4117-BADC-80C51C41D93FQ25256839-9066C9FC-C0BF-41F3-92B7-4791E0D40F13Q26797207-ECC1DA4E-CA20-4295-B427-8E5B4C5D03ECQ27023845-EF0EE6E3-6AE1-45AE-A16C-2A0CA8C785CEQ28083343-0813F65F-DDB1-4666-B20E-04D6EE5B9184Q28344916-DBBEECC1-6B3F-4A93-8FF2-A084E0FF3E9DQ28362626-F2DA029A-B4CC-4B0F-991B-DEC0969FF174Q28369263-68843832-A822-4DC1-BB58-A858D1DAF919Q30494961-C5F78A75-5666-463C-8E42-891799C9158EQ31116190-9E998210-A199-4A78-B607-BA30070B4651Q33617875-B20BA0CD-DB2E-4E9D-A7B5-0C212004D928Q33624843-1572D9C6-33F9-4DF9-AA27-B538F884EAD1Q33779745-4C93A56E-1BEF-4BDD-8DF5-A8BF826DC137Q33796554-29D4A122-CD74-47DD-8C86-9DE9C2F7815AQ33796559-C9D966D2-5633-43C5-82C4-D4CFC5BCA4C0Q34045455-9889100E-849C-46DB-BA76-F052335F8CF4Q34118386-6A6F6009-BAFC-4710-9B7C-D42842B9FA38Q34134282-4BC3AFC6-1123-492E-88DF-443456DF91A3Q34136314-8C5AFF07-7243-4172-9941-1F5D7FBAEBABQ34165145-65A7E7AC-8FBF-4B77-916B-4FD115BA808CQ34170508-8DDC0BF0-2E0E-40ED-9001-904520760C48Q34378716-1669D923-E7A9-4E62-9E5E-B5F7675B9CB8Q34396281-C97C2D1A-12DA-4E36-917C-8637407F1469Q34409596-5A1870A3-30A9-4ED5-A17D-EA280A501A29Q34409640-29AB0CAB-7EA5-477F-848D-FED9E5D7DF9BQ34432899-F56AD3D2-4CF2-4407-86D4-3F47E188FBC1Q34638729-2B6F22FC-B861-4BBF-B3A5-8C9FF0DAC640Q34772169-31B414D1-3D4E-4540-AF2B-B01EB0BFF612Q34833625-CAC6202B-5C36-4BB4-8E4D-FF22991F4164Q34992425-6B19A34F-EDBF-41A2-9DD1-7C2884A29F77Q35007536-B6341D76-9395-4324-A9FC-11CABC2DC3D8Q35022538-9220B61B-44E6-48EB-833A-90F1599399B4Q35051366-5D6365CE-6FEB-47C4-B93F-FE8656F1198EQ35177880-43E7FBF7-2CC2-4278-8BA2-0DAE55500FD3Q35189272-E52746D7-FDFC-4645-B76F-DA523297AA27Q35358222-86C27F4A-F706-40D6-AA2E-0D202E556AB6Q35364431-9973C788-10A2-4F3B-A0DA-1FE040BFB22EQ35521719-D8818D99-7C6C-42C2-9BE0-07101F1D1F1B
P2860
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
description
1991 nî lūn-bûn
@nan
1991 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@ast
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@en
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@nl
type
label
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@ast
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@en
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@nl
prefLabel
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@ast
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@en
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@nl
P2093
P1433
P1476
Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
@en
P2093
Pariente A
Trousset M
P304
P407
P577
1991-09-01T00:00:00Z